Content Restricted
This article is reserved for members with an active Standard Membership. Please purchase a Standard Membership to view this resource.
Purchase Standard Account
In Medicaid expansion states, 40.7% more people were treated with buprenorphine during 2014 through 2018 than in 2012 through 2013 prior to expansion. In non-expansion states, 42.7% more people were treated with treated with buprenorphine during 2014 through 2018 than in 2012 through 2013. However, the average quarterly number of all consumers treated with buprenorphine from 2014 through 2018 in expansion states increased by 9.8% more than in non-expansion states.
In the 26 Medicaid expansion states and District of Columbia, from 2012 through 2013, prior to Medicaid expansion, an average of 2,288,500 people . . .
